Towards a prognostic biomarker for multiple sclerosis

IF 69.2 1区生物学 Q1 MICROBIOLOGY

Nature Reviews Microbiology Pub Date : 2025-07-24 DOI:10.1038/s41579-025-01224-4

Andrea Du Toit

引用次数: 0

Abstract

The data in this study suggest that the detection of EBV nuclear antigen-specific antibodies are potentially an early marker predicting the diagnosis of multiple sclerosis.

查看原文本刊更多论文

迈向多发性硬化症的预后生物标志物

本研究的数据提示EBV核抗原特异性抗体的检测可能是预测多发性硬化症诊断的早期标志物。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Nature Reviews Microbiology 生物-微生物学

CiteScore

74.00

自引率

0.50%

发文量

149

审稿时长

6-12 weeks

期刊介绍： At Nature Reviews Microbiology, our goal is to become the leading source of reviews and commentaries for the scientific community we cater to. We are dedicated to publishing articles that are not only authoritative but also easily accessible, supplementing them with clear and concise figures, tables, and other visual aids. Our objective is to offer an unparalleled service to authors, referees, and readers, and we continuously strive to maximize the usefulness and impact of each article we publish. With a focus on Reviews, Perspectives, and Comments spanning the entire field of microbiology, our wide scope ensures that the work we feature reaches the widest possible audience.